Vor Bio to Participate in Upcoming Investor Conferences
2024年4月1日 - 9:00PM
Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering
company, today announced that it will participate in the following
upcoming investor conferences:
23rd Annual Needham Virtual Healthcare
ConferenceFireside Chat: Tuesday, April 9, 2024 at 3:45 pm
ET Location: Virtual
Chardan's 8th Annual Genetic Medicines +
Cell Therapy Manufacturing SummitFireside Chat: Monday,
April 29, 2024 at 9:30 am ET Location: Virtual
About Vor BioVor Bio is a
clinical-stage cell and genome engineering company that aims to
change the standard of care for patients with blood cancers by
engineering hematopoietic stem cells to enable targeted therapies
post-transplant. For more information, visit: www.vorbio.com.
Contact:
Media & InvestorsSarah Spencer +1
857-242-6076sspencer@vorbio.com
Vor Biopharma (NASDAQ:VOR)
過去 株価チャート
から 4 2024 まで 5 2024
Vor Biopharma (NASDAQ:VOR)
過去 株価チャート
から 5 2023 まで 5 2024
